| Farsi-language VISs |
|
|
|
|
|
| You
are encouraged to distribute the current English version
at the same time as the translation. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs. |
|
|
|
| FARSI TRANSLATION OF THE DECEMBER 16, 1998 CHICKENPOX VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Section 1: The answer has been rewritten by CDC. |
|
|
|
| • |
|
Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years. |
|
|
|
| • |
|
CDC added information on MMRV. |
|
|
|
| • |
|
The URL for Vaccine Adverse Event Reporting System (VAERS) has changed. |
|
|
|
| • |
|
The URL for the National Vaccine Injury Compensation Programs has changed. |
|
|
|
|
| FARSI TRANSLATION OF THE JULY 30, 2001 DTAP VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
The main change is in Section 4, which now mentions Tdap. |
|
|
|
| • |
|
The NVICP and VAERS web addresses have also been updated |
|
|
|
| • |
|
The mortality rate for tetanus in Section 1 changed from 1 out of 10, to 2 out of 10 cases. |
|
|
|
| • |
|
The date changed to 5/17/07. |
|
|
|
|
| FARSI TRANSLATION OF THE JULY 11, 2001 HEPATITIS B VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children. |
|
|
|
| • |
|
A final version will be developed. |
|
|
|
|
| FARSI TRANSLATION OF THE DECEMBER 16, 1998 MMR VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions. |
|
|
|
| • |
|
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately. |
|
|
|
|
| FARSI TRANSLATION OF THE SEPTEMBER 30, 2002 PNEUMOCOCCAL VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
The CDC posted an updated interim PCV VIS on 12/9/08. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem. |
|
|
|
|
| FARSI TRANSLATION OF THE JUNE 10, 1994 TD VIS |
|
| *Td VIS was replaced on November 18, 2008 with the Td/Tdap VIS |
|
| For the out-of-date Td translation, visit the Td/Tdap VIS section |
|
| Thanks to the California Department of Health Services for their translations. |
|
| This page was updated on November 16, 2009 |
Immunization Action Coalition
IAC Home